Person

Anthony Vocat

This person is no longer with EPFL

Related publications (28)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Anthony Vocat

Graph Chatbot

Chat with Graph Search

Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform

Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis

Synthesis and Structure-Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin

Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma

Synthesis, biology, computational studies and in vitro controlled release of new isoniazid-based adamantane derivatives

Design, Synthesis and in vitro Controlled Release of New Adamantanodiarylketone Antimycobacterials

Synthesis of diphenoxyadamantane alkylamines with pharmacological interest

Synthesis of New Indole and Adamantane Amido Derivatives with Pharmacological Interest

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)